Day: July 7, 2021

STAT+: Pharmalittle: Another lawmaker calls for probe of FDA approval of Alzheimer’s drug; Roche urged to lower price of Covid-19 therapy

Top of the morning to you. Another busy day is unfolding here on the Pharmalot campus, where we are mulling over our cluttered calendar and plotting our next moves. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. This calls, as […]

Opinion: Listen: A biostatistician on the ‘gold mine’ in our sewers

What if every time we went to the bathroom, we could say we contributed to a local public health initiative? In this week’s episode of the “First Opinion Podcast,” biostatistician Aparna Keshaviah digs into the benefits of wastewater testing as a public health measure. Sewers carry all sorts of information about a community, including the […]

How Doximity parlayed its popularity with doctors into a blockbuster IPO

Doximity exploded onto the public markets last month with an IPO that saw share values of the physician social networking startup double in 24 hours. The company raised $500 million — and the eyebrows of many industry observers — with its stock market debut, its first public fundraise since 2014. More than 10,000 physicians participated in […]

Opinion: Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases

The FDA’s decision to grant accelerated approval to Biogen’s aducanumab (Aduhelm) for the treatment of Alzheimer’s disease was a difficult and bold one that people with the disease, their families, and other drug developers should be applauding. When it comes to making new therapies for complex, difficult-to-treat diseases, history has shown that progress can’t be […]

Organ donations held almost steady during the pandemic, as the U.S. transplant system scrambled to keep going

This is not a pandemic “silver lining” story. This is a could-have-been-far-worse story about how the pandemic did not fuel a catastrophe in transplantation or worsen the persistent gap between people who need organs and the donations that supply them. But just as the pandemic is not over yet, neither is the potential danger of […]

Scroll to top